Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glycosphingolipids as mediators of phenotypic changes associated with development and cancer progression.

Journal of biochemistry - 1 Jan 2010

Igarashi Yasuyuki, Kannagi Reiji

Abstract excerpt

Sen-itiroh Hakomori has been involved for the past approximately 40 years in studies on structure and function of glycosphingolipids (GSLs). The following is a brief summary of highlights of his research, performed in association with his colleagues.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Glycosphingolipids
Share to Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Phenotype

Source

Identifiers

PMID: 20051388
DOI: 10.1093/jb/mvp195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glycosphingolipids as mediators of phenotypic changes associated with development and cancer progression.PMID 20051388Read ↗

Glycans in cancer and inflammation — potential for therapeutics and diagnosticsSemantic proximity Read ↗

Potential Role of Sphingolipidoses-Associated Lysosphingolipids in CancerSemantic proximity Read ↗

[A vital role for glycosphingolipid synthesis during development and differentiation].Semantic proximity Read ↗

Sphingolipid metabolism in the development and progression of cancer: one cancer's help is another's hindranceSemantic proximity Read ↗

The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistanceSemantic proximity Read ↗

Glycoconjugates from extracellular vesicles: Structures, functions and emerging potential as cancer biomarkersSemantic proximity Read ↗

The SPPL3-defined glycosphingolipid repertoire orchestrates HLA class I-mediated immune responsesSemantic proximity Read ↗

Dihydroceramides: their emerging physiological roles and functions in cancer and metabolic diseasesSemantic proximity Read ↗

Bilayer Forming Phospholipids as Targets for Cancer TherapySemantic proximity Read ↗

Impact of Nutrition on Sphingolipid‐Regulated Physiology: A ReviewSemantic proximity Read ↗

Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiologySemantic proximity Read ↗

Roles of PI3K/AKT/PTEN Pathway as a Target for Pharmaceutical TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.